No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:172949800-172960800 |
Bivalent/Poised TSS |
Fetal Brain Female |
brain
|
2 |
chr2:172950400-172959000 |
Weak transcription |
Hela-S3 |
cervix
|
3 |
chr2:172951400-172955600 |
Weak transcription |
Dnd41 |
blood
|
4 |
chr2:172951800-172957600 |
Weak transcription |
K562 |
blood
|
5 |
chr2:172953000-172956000 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
6 |
chr2:172953600-172956400 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
7 |
chr2:172953600-172957800 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
8 |
chr2:172953800-172956200 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
9 |
chr2:172954400-172956000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
10 |
chr2:172954400-172962600 |
Bivalent/Poised TSS |
Brain Germinal Matrix |
brain
|
11 |
chr2:172954600-172955600 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
12 |
chr2:172954600-172956200 |
Bivalent/Poised TSS |
Cortex derived primary cultured neurospheres |
brain
|
13 |
chr2:172954600-172956600 |
Weak transcription |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
14 |
chr2:172954800-172955600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
15 |
chr2:172954800-172955600 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
16 |
chr2:172954800-172955600 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
17 |
chr2:172954800-172956000 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
18 |
chr2:172954800-172956000 |
Bivalent Enhancer |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
19 |
chr2:172954800-172956000 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
20 |
chr2:172954800-172957600 |
Active TSS |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
21 |
chr2:172955000-172955600 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
22 |
chr2:172955200-172955600 |
Bivalent Enhancer |
Spleen |
Spleen
|
23 |
chr2:172955200-172955600 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
24 |
chr2:172955200-172956000 |
Bivalent Enhancer |
Primary T helper memory cells from peripheral blood 1 |
blood
|
25 |
chr2:172955200-172956000 |
Bivalent Enhancer |
Primary T helper 17 cells PMA-I stimulated |
--
|
26 |
chr2:172955400-172955600 |
Flanking Bivalent TSS/Enh |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
27 |
chr2:172955400-172955600 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
28 |
chr2:172955400-172955600 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
29 |
chr2:172955400-172955600 |
Bivalent Enhancer |
Left Ventricle |
heart
|
30 |
chr2:172955400-172955600 |
Bivalent Enhancer |
Monocytes-CD14+_RO01746 |
blood
|
31 |
chr2:172955400-172955800 |
Bivalent Enhancer |
Primary T helper naive cells fromperipheralblood |
blood
|
32 |
chr2:172955400-172956000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
33 |
chr2:172955400-172956000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|